Endava Announces First Quarter Fiscal Year 2023 Results
Endava plc (NYSE: DAVA) reported a robust Q1 FY2023 with revenue increasing by 33.0% year-on-year to £196.2 million, and a 25.9% revenue growth rate at constant currency. The diluted EPS rose to £0.55 from £0.36 a year ago, reflecting strong demand across all regions. Profit before tax also increased, reaching £38.6 million. Despite a slowdown in revenue growth rate compared to the previous period, positive outlooks suggest Q2 revenues are expected to be between £204.0 million and £206.0 million.
- Revenue increased by 33.0% year-on-year to £196.2 million.
- Diluted EPS rose to £0.55 compared to £0.36 in Q1 FY2022.
- Adjusted diluted EPS improved to £0.54 from £0.49 year-on-year.
- Net cash from operating activities grew to £25.2 million.
- Revenue growth rate at constant currency decreased to 25.9% from 60.8% year-on-year.
- Adjusted profit before tax as a percentage of revenue dropped to 20.1% from 23.6%.
Q1 FY2023
IFRS diluted EPS
Adjusted diluted EPS
“Endava reported another solid quarter for Q1 FY2023 as demand for our services across all regions and verticals in which we operate remains strong, despite the global macroeconomic uncertainty,” said
FIRST QUARTER FISCAL YEAR 2023 FINANCIAL HIGHLIGHTS:
-
Revenue for Q1 FY2023 was
£196.2 million , an increase of33.0% compared to£147.5 million in the same period in the prior year. -
Revenue growth rate at constant currency (a non-IFRS measure)* was
25.9% for Q1 FY2023, compared to60.8% in the same period in the prior year. -
Profit before tax for Q1 FY2023 was
£38.6 million , compared to£24.9 million in the same period in the prior year. -
Adjusted profit before tax (a non-IFRS measure)* for Q1 FY2023 was
£39.5 million , compared to£34.8 million in the same period in the prior year, or20.1% of revenue, compared to23.6% of revenue in the same period in the prior year. -
Profit for the period was
£31.7 million in Q1 FY2023, resulting in a diluted EPS of£0.55 , compared to profit of£20.5 million and diluted EPS of£0.36 in the same period in the prior year. -
Adjusted profit for the period (a non-IFRS measure)* was
£31.3 million in Q1 FY2023, resulting in adjusted diluted EPS (a non-IFRS measure)* of£0.54 , compared to adjusted profit for the period of£28.3 million and adjusted diluted EPS of£0.49 in the same period in the prior year.
CASH FLOW:
-
Net cash from operating activities was
£25.2 million in Q1 FY2023, compared to£19.9 million in the same period in the prior year. -
Adjusted free cash flow (a non-IFRS measure)* was
£21.8 million in Q1 FY2023, compared to£16.5 million in the same period in the prior year. -
At
September 30, 2022 ,Endava had cash and cash equivalents of£182.4 million , compared to£162.8 million atJune 30, 2022 .
* Definitions of the non-IFRS measures used by the Company and a reconciliation of such measures to the related IFRS financial measure can be found under the sections below titled “Non-IFRS Financial Information” and “Reconciliation of IFRS Financial Measures to Non-IFRS Financial Measures.”
OTHER METRICS FOR THE QUARTER ENDED
-
Headcount reached 12,065 at
September 30, 2022 , with 10,956 average operational employees in Q1 FY2023, compared to a headcount of 9,616 atSeptember 30, 2021 and 8,483 average operational employees in the same quarter of the prior year. -
Number of clients with over
£1 million in revenue on a rolling twelve month basis was 140 atSeptember 30, 2022 , compared to 93 atSeptember 30, 2021 . -
Top 10 clients accounted for
33% of revenue in Q1 FY2023, compared to36% in the same period in the prior year. -
By geographic region,
35% of revenue was generated inNorth America ,22% was generated inEurope ,40% was generated in theUnited Kingdom and3% was generated in the rest of the world in Q1 FY2023. This compares to36% inNorth America ,20% inEurope ,41% in theUnited Kingdom and3% in the rest of the world in the same period in the prior year. -
By industry vertical,
52% of revenue was generated from Payments and Financial Services,23% from TMT and25% from Other in Q1 FY2023. This compares to50% from Payments and Financial Services,25% from TMT and25% from Other in the same period in the prior year.
OUTLOOK:
Second Quarter Fiscal Year 2023:
Full Fiscal Year 2023:
This above guidance for Q2 Fiscal Year 2023 and the Full Fiscal Year 2023 assumes the exchange rates at the end of
The guidance provided above is forward-looking in nature. Actual results may differ materially. See the cautionary note regarding “Forward-Looking Statements” below.
CONFERENCE CALL DETAILS:
The Company will host a conference call at
Investors may listen to the call on Endava’s Investor Relations website at http://investors.Endava.com. The webcast will be recorded and available for replay until
ABOUT
NON-IFRS FINANCIAL INFORMATION:
To supplement Endava’s Consolidated Statements of Comprehensive Income, Consolidated Balance Sheets and Consolidated Statements of Cash Flow presented in accordance with IFRS, the Company uses non-IFRS measures of certain components of financial performance. These measures include: revenue growth rate at constant currency, adjusted profit before tax, adjusted profit for the period, adjusted diluted EPS and adjusted free cash flow.
Revenue growth rate at constant currency is calculated by translating revenue from entities reporting in foreign currencies into British Pounds using the comparable foreign currency exchange rates from the prior period. For example, the average rates in effect for the fiscal quarter ended
Adjusted profit before tax ("Adjusted PBT") is defined as the Company’s profit before tax adjusted to exclude the impact of share-based compensation expense, amortisation of acquired intangible assets, realised and unrealised foreign currency exchange (gains)/losses and fair value movement of contingent consideration, all of which are non-cash items. Adjusted PBT margin is Adjusted PBT as a percentage of total revenue.
Adjusted profit for the period is defined as Adjusted PBT together with the tax impact of these adjustments.
Adjusted diluted EPS is defined as Adjusted profit for the period, divided by weighted average number of shares outstanding - diluted.
Adjusted free cash flow is the Company’s net cash from operating activities, plus grants received, less net purchases of non-current assets (tangible and intangible).
Management believes these measures help illustrate underlying trends in the Company's business and uses the measures to establish budgets and operational goals, communicated internally and externally, for managing the Company's business and evaluating its performance. Management also believes the presentation of its non-IFRS financial measures enhances an investor’s overall understanding of the Company’s historical financial performance. The presentation of the Company’s non-IFRS financial measures is not meant to be considered in isolation or as a substitute for the Company’s financial results prepared in accordance with IFRS, and its non-IFRS measures may be different from non-IFRS measures used by other companies. Investors should review the reconciliation of the Company’s non-IFRS financial measures to the comparable IFRS financial measures included below, and not rely on any single financial measure to evaluate the Company’s business.
FORWARD-LOOKING STATEMENTS:
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the use of terms and phrases such as “believe,” “expect,” "outlook," “may,” “will,” and other similar terms and phrases. Such forward-looking statements include, but are not limited to, the statements regarding Endava’s projected financial performance for the second fiscal quarter of fiscal year 2023 and the full fiscal year 2023. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: Endava’s business, results of operations and financial condition may be negatively impacted by the COVID 19 pandemic and the
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
Three Months Ended
|
|||
|
2022 |
2021 |
||
|
£’000 |
£’000 |
||
REVENUE |
196,169 |
|
147,465 |
|
Cost of sales |
|
|
||
Direct cost of sales |
(122,971 |
) |
(89,486 |
) |
Allocated cost of sales |
(5,783 |
) |
(5,290 |
) |
Total cost of sales |
(128,754 |
) |
(94,776 |
) |
GROSS PROFIT |
67,415 |
|
52,689 |
|
Selling, general and administrative expenses |
(38,878 |
) |
(27,643 |
) |
Net impairment (losses) / gains on financial assets |
(1,304 |
) |
(1,161 |
) |
OPERATING PROFIT |
27,233 |
|
23,885 |
|
Net Finance income / (expense) |
11,335 |
|
1,037 |
|
PROFIT BEFORE TAX |
38,568 |
|
24,922 |
|
Tax on profit on ordinary activities |
(6,840 |
) |
(4,377 |
) |
PROFIT FOR THE PERIOD |
31,728 |
|
20,545 |
|
OTHER COMPREHENSIVE INCOME |
|
|
||
Items that may be reclassified subsequently to profit or loss: |
|
|
||
Exchange differences on translating foreign operations |
7,980 |
|
2,049 |
|
TOTAL COMPREHENSIVE INCOME FOR THE PERIOD ATTRIBUTABLE TO OWNERS OF THE PARENT |
39,708 |
|
22,594 |
|
|
|
|
||
EARNINGS PER SHARE (EPS): |
|
|
||
Weighted average number of shares outstanding - Basic |
56,705,849 |
|
55,649,000 |
|
Weighted average number of shares outstanding - Diluted |
58,128,971 |
|
57,792,616 |
|
Basic EPS (£) |
0.56 |
|
0.37 |
|
Diluted EPS (£) |
0.55 |
|
0.36 |
|
CONDENSED CONSOLIDATED BALANCE SHEETS
|
|
|
|
|||
|
£’000 |
£’000 |
£’000 |
|||
ASSETS - NON-CURRENT |
|
|
|
|||
|
152,604 |
|
145,916 |
|
128,165 |
|
Intangible assets |
56,354 |
|
56,189 |
|
60,601 |
|
Property, plant and equipment |
23,460 |
|
21,260 |
|
15,484 |
|
Lease right-of-use assets |
59,490 |
|
50,818 |
|
55,130 |
|
Deferred tax assets |
19,611 |
|
17,218 |
|
25,335 |
|
Financial assets |
2,793 |
|
2,276 |
|
225 |
|
TOTAL |
314,312 |
|
293,677 |
|
284,940 |
|
ASSETS - CURRENT |
|
|
|
|||
Trade and other receivables |
190,760 |
|
162,671 |
|
141,511 |
|
Corporation tax receivable |
2,940 |
|
2,309 |
|
864 |
|
Financial assets |
346 |
|
392 |
|
565 |
|
Cash and cash equivalents |
182,395 |
|
162,806 |
|
82,034 |
|
TOTAL |
376,441 |
|
328,178 |
|
224,974 |
|
TOTAL ASSETS |
690,753 |
|
621,855 |
|
509,914 |
|
LIABILITIES - CURRENT |
|
|
|
|||
Lease liabilities |
12,945 |
|
11,898 |
|
13,007 |
|
Trade and other payables |
102,244 |
|
98,252 |
|
85,866 |
|
Corporation tax payable |
11,878 |
|
3,477 |
|
7,526 |
|
Contingent consideration |
1,340 |
|
4,183 |
|
5,904 |
|
Deferred consideration |
12,401 |
|
10,604 |
|
5,094 |
|
TOTAL |
140,808 |
|
128,414 |
|
117,397 |
|
LIABILITIES - NON CURRENT |
|
|
|
|||
Lease liabilities |
51,321 |
|
43,999 |
|
47,548 |
|
Contingent consideration |
3,040 |
|
4,331 |
|
— |
|
Deferred tax liabilities |
10,507 |
|
10,826 |
|
9,667 |
|
Deferred consideration |
— |
|
1,062 |
|
4,633 |
|
Other liabilities |
512 |
|
500 |
|
209 |
|
TOTAL |
65,380 |
|
60,718 |
|
62,057 |
|
EQUITY |
|
|
|
|||
Share capital |
1,135 |
|
1,135 |
|
1,114 |
|
Share premium |
9,173 |
|
9,152 |
|
247 |
|
Merger relief reserve |
30,003 |
|
30,003 |
|
30,003 |
|
Retained earnings |
441,943 |
|
398,102 |
|
310,801 |
|
Other reserves |
2,466 |
|
(5,514 |
) |
(11,550 |
) |
Investment in own shares |
(155 |
) |
(155 |
) |
(155 |
) |
TOTAL |
484,565 |
|
432,723 |
|
330,460 |
|
TOTAL LIABILITIES AND EQUITY |
690,753 |
|
621,855 |
|
509,914 |
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
|
Three Months Ended
|
|||
|
2022 |
2021 |
||
|
£’000 |
£’000 |
||
OPERATING ACTIVITIES |
|
|
||
Profit for the period |
31,728 |
|
20,545 |
|
Income tax charge |
6,840 |
|
4,377 |
|
Non-cash adjustments |
6,099 |
|
14,742 |
|
Tax paid |
(1,610 |
) |
(2,233 |
) |
Net changes in working capital |
(17,821 |
) |
(17,522 |
) |
Net cash from operating activities |
25,236 |
|
19,909 |
|
|
|
|
||
INVESTING ACTIVITIES |
|
|
||
Purchase of non-current assets (tangibles and intangibles) |
(3,443 |
) |
(3,562 |
) |
Proceeds from disposal of non-current assets |
19 |
|
112 |
|
Payment for acquisition of subsidiary, net of cash acquired |
— |
|
(611 |
) |
Interest received |
365 |
|
9 |
|
Net cash used in investing activities |
(3,059 |
) |
(4,052 |
) |
|
|
|
||
FINANCING ACTIVITIES |
|
|
||
Proceeds from sublease |
145 |
|
135 |
|
Repayment of lease liabilities |
(3,099 |
) |
(3,801 |
) |
Interest paid |
(217 |
) |
(249 |
) |
Grant received |
— |
|
1 |
|
Issue of shares |
21 |
|
— |
|
Net cash (used in)/from financing activities |
(3,150 |
) |
(3,914 |
) |
Net change in cash and cash equivalents |
19,027 |
|
11,943 |
|
|
|
|
||
Cash and cash equivalents at the beginning of the period |
162,806 |
|
69,884 |
|
Exchange differences on cash and cash equivalents |
562 |
|
207 |
|
Cash and cash equivalents at the end of the period |
182,395 |
|
82,034 |
|
RECONCILIATION OF IFRS FINANCIAL MEASURES TO NON-IFRS FINANCIAL MEASURES
RECONCILIATION OF REVENUE GROWTH RATE AS REPORTED UNDER IFRS TO REVENUE GROWTH RATE AT CONSTANT CURRENCY:
Three Months ended
|
||||
|
2022 |
2021 |
||
REVENUE GROWTH RATE AS REPORTED UNDER IFRS |
33.0 |
% |
55.0 |
% |
Foreign exchange rates impact |
(7.1 |
%) |
5.8 |
% |
REVENUE GROWTH RATE AT CONSTANT CURRENCY |
25.9 |
% |
60.8 |
% |
RECONCILIATION OF ADJUSTED PROFIT BEFORE TAX AND ADJUSTED PROFIT FOR THE PERIOD:
|
Three Months Ended
|
|||
|
2022 |
2021 |
||
|
£’000 |
£’000 |
||
|
|
|
||
PROFIT BEFORE TAX |
38,568 |
|
24,922 |
|
Adjustments: |
|
|
||
Share-based compensation expense |
9,544 |
|
9,158 |
|
Amortisation of acquired intangible assets |
3,019 |
|
2,461 |
|
Foreign currency exchange (gains) / losses, net |
(7,414 |
) |
(1,757 |
) |
Fair value movement of contingent consideration |
(4,249 |
) |
— |
|
Total adjustments |
900 |
|
9,862 |
|
ADJUSTED PROFIT BEFORE TAX |
39,468 |
|
34,784 |
|
|
|
|
||
PROFIT FOR THE PERIOD |
31,728 |
|
20,545 |
|
Adjustments: |
|
|
||
Adjustments to profit before tax |
900 |
|
9,862 |
|
Tax impact of adjustments |
(1,330 |
) |
(2,107 |
) |
ADJUSTED PROFIT FOR THE PERIOD |
31,298 |
|
28,300 |
|
|
|
|
||
Diluted EPS (£) |
0.55 |
|
0.36 |
|
Adjusted diluted EPS (£) |
0.54 |
|
0.49 |
|
RECONCILIATION OF NET CASH FROM OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
|
Three Months Ended
|
|||
|
2022 |
2021 |
||
|
£’000 |
£’000 |
||
|
|
|
||
Net cash from operating activities |
25,236 |
|
19,909 |
|
Adjustments: |
|
|
||
Grant received |
— |
|
1 |
|
Purchases of non-current assets (tangibles and intangibles) |
(3,424 |
) |
(3,450 |
) |
Adjusted Free cash flow |
21,812 |
|
16,460 |
|
SUPPLEMENTARY INFORMATION
SHARE-BASED COMPENSATION EXPENSE
|
Three Months Ended
|
|
|
2022 |
2021 |
|
£’000 |
£’000 |
|
|
|
Direct cost of sales |
5,957 |
5,346 |
Selling, general and administrative expenses |
3,587 |
3,812 |
Total |
9,544 |
9,158 |
DEPRECIATION AND AMORTISATION
|
Three Months Ended
|
|
|
2022 |
2021 |
|
£’000 |
£’000 |
|
|
|
Direct cost of sales |
4,087 |
3,916 |
Selling, general and administrative expenses |
3,618 |
3,057 |
Total |
7,705 |
6,973 |
EMPLOYEES, TOP 10 CUSTOMERS AND REVENUE SPLIT
|
Three Months Ended
|
|||
|
2022 |
2021 |
||
|
|
|
||
Closing number of total employees (including directors) |
12,065 |
|
9,616 |
|
Average operational employees |
10,956 |
|
8,483 |
|
|
|
|
||
Top 10 customers % |
33 |
% |
36 |
% |
Number of clients with > (rolling 12 months) |
140 |
|
93 |
|
|
|
|
||
Geographic split of revenue % |
|
|
||
|
35 |
% |
36 |
% |
|
22 |
% |
20 |
% |
|
40 |
% |
41 |
% |
Rest of World (RoW) |
3 |
% |
3 |
% |
Industry vertical split of revenue % |
|
|
||
Payments and Financial Services |
52 |
% |
50 |
% |
TMT |
23 |
% |
25 |
% |
Other |
25 |
% |
25 |
% |
FOOTNOTES
(1) The Condensed Consolidated Balance Sheet as of
View source version on businesswire.com: https://www.businesswire.com/news/home/20221114005772/en/
INVESTOR CONTACT:
Investors@endava.com
Source:
FAQ
What were Endava's Q1 FY2023 earnings results?
What is Endava's revenue guidance for Q2 FY2023?
How did Endava's diluted EPS change in Q1 FY2023?